These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29923974)

  • 1. Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Medicine (Baltimore); 2018 Jun; 97(25):e10824. PubMed ID: 29923974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
    Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
    Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Tajiri H
    Oncology; 2013; 85(5):269-77. PubMed ID: 24217119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Sun P; Li Y; Chang L; Tian X
    Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer.
    Zhang Y; Cao J; Deng Y; Huang Y; Li R; Lin G; Dong M; Huang Z
    Clinics (Sao Paulo); 2020; 75():e993. PubMed ID: 32130355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
    Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
    J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.
    Zhang X; Long Q
    Medicine (Baltimore); 2017 Apr; 96(17):e6694. PubMed ID: 28445272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang X; Xin Y; Chen Y; Zhou X
    Sci Rep; 2023 Jan; 13(1):1808. PubMed ID: 36720974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
    Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
    Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies.
    Gan J; Wang W; Yang Z; Pan J; Zheng L; Yin L
    Medicine (Baltimore); 2018 Nov; 97(46):e13151. PubMed ID: 30431587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
    Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Xu L; Wu J; Lu W; Yang C; Liu H
    Transplant Proc; 2019 Dec; 51(10):3338-3346. PubMed ID: 31732203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis.
    Huang G; Jiang H; Lin Y; Wu Y; Cai W; Shi B; Luo Y; Jian Z; Zhou X
    Cancer Manag Res; 2018; 10():5027-5041. PubMed ID: 30464603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis.
    Li M; Wu Y; Zhang J; Huang L; Wu X; Yuan Y
    Medicine (Baltimore); 2019 Sep; 98(37):e16974. PubMed ID: 31517816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Li MX; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Zhao H; Cai JQ
    Medicine (Baltimore); 2015 Dec; 94(49):e2133. PubMed ID: 26656342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
    Hao Q; Han Y; Xia W; Wang Q; Qian H
    Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
    Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
    Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.